Venice, Italy

Enrico Rosso

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: F.i.s. Fabbrica Italiana Sintetici S.p.a.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Enrico Rosso. Retrieved from https://idiyas.com/inventor/enrico-rosso

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Enrico Rosso: Innovator in Pharmaceutical Chemistry

Introduction

Enrico Rosso is a notable inventor based in Venice, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of active pharmaceutical ingredients. His innovative work has led to the development of a key intermediate for the drug Omarigliptin.

Latest Patents

Enrico Rosso holds 1 patent for his invention titled "Process for the preparation of key intermediates of omarigliptin." This patent describes an improved process for synthesizing a crucial intermediate compound, which is essential for the production of Omarigliptin. The process involves converting a specific compound through a series of reactions, ultimately leading to the desired intermediate.

Career Highlights

Enrico Rosso is associated with F.i.s. Fabbrica Italiana Sintetici S.p.a., where he has been instrumental in advancing pharmaceutical synthesis techniques. His expertise in chemical processes has contributed to the company's reputation for innovation in the pharmaceutical industry.

Collaborations

Enrico has collaborated with notable colleagues such as Ottorino De Lucchi and Simone Zaramella. Their combined efforts have fostered a productive environment for research and development within their organization.

Conclusion

Enrico Rosso's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in drug development. His work continues to influence the synthesis of important pharmaceutical compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…